Breast cancer is the most commonly diagnosed malignant tumor in women worldwide and
contributes significantly as the primary cause of female cancer related mortality. Hence, …

Cancer has long been considered a genetic disease characterized by a myriad of mutations
that drive cancer progression. Recent accumulating evidence indicates that the …

Breast cancer is the most common malignancy in women worldwide, with a developmental
process spanning decades. The malignant cells recruit a variety of cells including fibroblasts, …

The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…

Adipocytes influence breast cancer behaviour via fatty acid release into the tumour
microenvironment. Co-culturing human adipocytes and breast cancer cells increased CD36 …

The tumour microenvironment is a key regulators of tumour progression through the secretion
of growth factors that activate epithelial-mesenchymal transition (EMT). Induction of EMT is …

The cooccurrence of diabetes mellitus and metabolic syndrome potentiates the cardiovascular
risk associated with each of the conditions; therefore characterizing metabolic syndrome …

The COVID-19 pandemic is one of the fastest evolving pandemics in recent history. As such,
the SARS-CoV-2 viral evolution needs to be continuously tracked. This study sequenced …

The microenvironment of breast cancer comprises predominantly of adipocytes. Adipocytes
drive cancer progression through the secretion adipocytokines. Adipocytes induce epithelial …

Ibrutinib and other targeted inhibitors of B-cell receptor signaling achieve impressive clinical
results for patients with chronic lymphocytic leukemia (CLL). A treatment-induced rise in …